tirzepatide for the treatment of obstructive sleep apnea and obesity Weight-loss drug Zepbound resolves in up to 52% patients, Lilly says Terzapatid in Managing OSA

Semaglutide is FDA-approved in different forms to treat type 2 diabetes and obesity, often used as an injection alongside a healthy diet and exercise

Studies investigating different coformulations of semaglutide and SNAC in healthy individuals showed that exposure of semaglutide 5 or 10 mg was higher with 300 mg SNAC compared with 150 or 600 mg, demonstrating that 300 mg SNAC is the optimal amount of SNAC to enhance the absorption of semaglutide (15,37)

"If you go to the Red Cross

These are benefits that surgery cant achieve

However, this means that the effects of treatment will be minimal until the target dose is reached and the titration period ends

It will be good to have a nonsurgical option to address both weight loss versus bariatric surgery and obstructive sleep apnea reduction vs upper airway surgery to remove excess tissue in the throat or auvulopalatopharyngoplasty. Monique May, MD, board certified family physician When previously interviewed about the top-line clinical trial results released in April 2024, May said she was surprised by the small number of participants